SOD1 and Parkinson disease: Given neither abnormal SOD1 nor dopamine neuron death, can be quantified in the living human brain, we developed the first mouse model expressing Parkinson-like wild-type SOD1 pathology to better understand the relationship between this pathology and dopamine neuron vulnerability.